单次推注或分次注射环磷酰胺或异环磷酰胺联合美司钠的治疗效果。 - Suppr

Suppr

超能文献

Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.

作者信息

Klein H O, Wickramanayake P D, Christian E, Coerper C, Graf L

出版信息

Cancer Treat Rev. 1983 Sep;10 Suppl A:83-92. doi: 10.1016/s0305-7372(83)80012-7.

DOI:10.1016/s0305-7372(83)80012-7

PMID:6414699

Abstract

摘要

相似文献

Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.单次推注或分次注射环磷酰胺或异环磷酰胺联合美司钠的治疗效果。

Cancer Treat Rev. 1983 Sep;10 Suppl A:83-92. doi: 10.1016/s0305-7372(83)80012-7.

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557).单剂量推注、分次注射或持续输注氮杂磷类药物（环磷酰胺、异环磷酰胺、Asta Z 7557）的治疗效果。

Cancer. 1984 Sep 15;54(6 Suppl):1193-203. doi: 10.1002/1097-0142(19840915)54:1+<1193::aid-cncr2820541317>3.0.co;2-z.

Infusion of ifosfamide plus mesna.异环磷酰胺加美司钠输注。

Lancet. 1984 Aug 25;2(8400):468. doi: 10.1016/s0140-6736(84)92946-5.

High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.高剂量异环磷酰胺和美司钠持续输注五天——一项I/II期试验。

Cancer Treat Rev. 1983 Sep;10 Suppl A:167-73. doi: 10.1016/s0305-7372(83)80025-5.

Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.阿霉素、异环磷酰胺和美司钠联合化疗治疗广泛期非小细胞支气管肺癌

Cancer Treat Rev. 1983 Sep;10 Suppl A:121-3. doi: 10.1016/s0305-7372(83)80016-4.

Infusion of ifosphamide plus mesna.异环磷酰胺加美司钠输注。

Lancet. 1984 Jun 16;1(8390):1353-4. doi: 10.1016/s0140-6736(84)91847-6.

High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.晚期软组织肉瘤中高剂量异环磷酰胺联合美司钠静脉输注治疗。

Cancer Treat Rev. 1983 Sep;10 Suppl A:163-4. doi: 10.1016/s0305-7372(83)80023-1.

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.使用异环磷酰胺输注联合美司钠进行大剂量烷基化疗法治疗成人晚期软组织肉瘤。

Cancer Chemother Pharmacol. 1983;11(2):69-72. doi: 10.1007/BF00254247.

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.异环磷酰胺治疗难治性恶性疾病的疗效及美司钠的尿路保护作用：一项针对151例患者的II期临床研究结果

Cancer Treat Rev. 1983 Sep;10 Suppl A:93-101. doi: 10.1016/s0305-7372(83)80013-9.

Ifosfamide/mesa and encephalopathy.异环磷酰胺/美司钠与脑病

Lancet. 1985 Mar 30;1(8431):752. doi: 10.1016/s0140-6736(85)91288-7.

引用本文的文献

Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide).环磷酰胺一种稳定的细胞生长抑制剂代谢物（ASTA Z 7557，国际非专利药品名称马磷酰胺）的毒性及治疗效果的临床前评估

Invest New Drugs. 1984;2(2):191-9. doi: 10.1007/BF00232351.

Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.异环磷酰胺治疗食管表皮样癌的II期试验：意外的严重毒性。

Invest New Drugs. 1988 Sep;6(3):239-41. doi: 10.1007/BF00175406.

Toxicity of high-dose ifosfamide in children.

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S8-10. doi: 10.1007/BF00253229.

High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.高剂量异环磷酰胺联合美司钠进行尿路保护治疗尤因肉瘤。

Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4. doi: 10.1007/BF00253239.

Basic principles in preclinical cancer chemotherapy.临床前癌症化疗的基本原则。

J Cancer Res Clin Oncol. 1990;116(5):411-24. doi: 10.1007/BF01612986.

Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.高剂量异环磷酰胺和美司钠治疗宫颈癌：一项GETLAC研究

Cancer Chemother Pharmacol. 1990;26 Suppl:S1-3. doi: 10.1007/BF00685406.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验